VTCN1 and cancer: Recent studies have shown that B7-H4 can inhibit the proliferation, activation and cytokine secretion of T cells in tumor environment, and the B7-H4 expression is associated with many clinicopathological parameters such as tumor size, primary tumor classification, TNM malignant tumor score, overall survival, and tumor infiltrating T cells [3, 4].